Childhood cancers: open trials in Portugal

19 open trials have a site in Portugal. Registry data; only the trial team decides who can take part.

NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
START Lisbon - Hospital de Santa Maria (Site 2601), Lisbon · Instituto Portugues de Oncologia Do Porto Francisco Gentil E.P.E. (Site 2600), Porto
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-11-02
NCT05376891
Met Non Small Cell Cancer Registry (MOMENT)
Research · EMD Serono Research & Development Institute, Inc.
Centro Hospitalar de Lisboa Norte, EPE - Hospital de Santa Maria, Lisbon · ULS de Loures-Odivelas, EPE - Hospital de Loures, Loures · Centro Hospitalar do Porto, E.P.E. - Hospital de Santo António, Porto · Instituto Portugues de Oncologia Do Porto Francisco Gentil Epe - PPDS, Porto Covo
Registry updated 2026-10-29
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Instituto Português de Oncologia de Lisboa, Lisbon
Registry updated 2026-10-26
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Unidade Local De Saude De Sao Jose E.P.E., Lisbon · Unidade Local De Saude De Santa Maria E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto · Unidade Local De Saude De Santo Antonio E.P.E., Porto
Registry updated 2026-10-21
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Centro Hospitalar E Universitărio de Coimbra E.P.E., Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-10-19
NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Instituto Portugues De Oncologia De Coimbra Francisco Gentil E.P.E., Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Hospital da Luz, S.A, Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-10-06
2023-504999-25-00
CHIP-AML22 Master protocol: Protocol for the treatment of children and adolescents with Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Prinses Maxima Centrum voor Kinderoncologie B.V.
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-09-23
NCT04307576
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 3 · Mats Heyman
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-08-12
NCT04685616
Brentuximab Vedotin in Early Stage Hodgkin Lymphoma
Trial Treatment · Phase 3 · University College, London
Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon
Registry updated 2026-07-08
NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-07-06
NCT04877522
Asciminib Roll-over Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-07-06
NCT02834884
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
Research · European Organisation for Research and Treatment of Cancer - EORTC
Instituto Portugues De Oncologia - Centro De Coimbra, Coimbra · Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon · Centro Hospitalar de Lisboa Ocidental- San Francisco Xavier Hospital, Lisbon · Hospital CUF Descobertas, Lisbon · Hospital Cuf Tejo, Lisbon · Centro Hospitalar do Porto - Hospital de Santo António, Porto · Instituto Portugues de Oncologia do Porto, Porto · Unidade Local de Saúde Gaia e Espinho, Vila Nova de Gaia
Registry updated 2026-06-24
NCT04043494
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma
Trial Treatment · Phase 3 · University Hospital Muenster
Centro Hospitalar e Universitario de Coimbra, Coimbra · Instituto Português de Oncologia - Francisco Gentil - Libosa, Lisbon · Instituto Português de Oncologia - Francisco Gentil - Porto, Porto
Registry updated 2026-05-06
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2026-03-17
NCT06262438
CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients
Trial Treatment · Phase 2 · Princess Maxima Center for Pediatric Oncology
Unidade Local de Saúde de Coimbra, E.P.E., Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2025-08-05
NCT06848270
Effectiveness of Early Intervention in Palliative Care for Acute Myeloid Leukemia Patients Comparing to Standard of Care
Trial Treatment · Universidade do Porto
Centro Hospitalar e Universitário de São João, Porto
Registry updated 2025-02-27
NCT04625907
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
Trial Treatment · Phase 1/2 · University of Birmingham
Centro Hospitalar Universitario de Coimbra, Coimbra · Instituto Portugues de Oncologia de Lisboa Francisco Gentil, E.P.E., Lisbon · Centro Hospitalar Universitário de São João, Porto · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2024-05-23
NCT04793919
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Trial Treatment · Phase 2 · Associazione Italiana Ematologia Oncologia Pediatrica
Centro Hospitalar Universitário de Coimbra - Hospital Pediátrico de Coimbra, Coimbra · Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE, Lisbon · Instituto Portugues de Oncologia do Porto Francisco Gentil, E.P.E., Porto
Registry updated 2024-04-15

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error